EPGL really needs to demonstrate that there is a market for MPDD! Without the huge revenue required from projected sales, how are they going to fund R&D and FDA approvals let alone buy back shares?
Confirmation (or lack thereof) of MPDD sales should be #1 on stockholder's minds...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.